Japanese Pharmacology and Therapeutics
Torres-lvarez et al, 2011)
The EMBRAZE trials placebo arm found that 30 per cent of total weight loss with tirzepatide alone came from lean mass, consistent with the 30 to 40 per cent range observed across the GLP-1 class more broadly.3,5 For an older patient already experiencing age-related muscle loss, that proportion is not incidental
Many people notice: Nausea occurs more quickly Reflux and stomach upset aggravate Alcohol hits harder Blood sugar levels fluctuate faster It is also important to remember that alcohol
All GLP-1s are clinically-tested, stimulant-free, and non-habit forming
The most effective solutions include strategic protein timing, electrolyte supplementation, B12 optimization, and sleep quality improvements